1. Generic Drug User Fee Act Reauthorization (GDUFA II), Biosimilar User Fee Act Reauthorization (BsUFA II). https://www.fda.gov/NewsEvents/Testimony/ucm548273.htm. Accessed August 14, 2017.
2. Association of Accessible Medications. 2017 generic drug access and savings in the United States report. https://www.accessiblemeds.org/resources/blog/2017-generic-drug-access-and-savings-us-report. Accessed October 19, 2017.
3. Generic Drug User Fee Act I. https://www.fda.gov/ForIndustry/UserFees/GenericDrugUserFees/ucm476659.htm.
4. Abbreviated New Drug Application (ANDA): Generics. https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/default.htm.
5. Manual of Policies and Procedures Office of Generic Drugs Filing Review of Abbreviated New Drug Applications. https://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ManualofPoliciesProcedures/UCM574493.pdf.